Kole Roybal is an Assistant Professor in the Department of Microbiology and Immunology and the Helen Diller Comprehensive Cancer Center at the University of California, San Francisco. His lab harnesses the tools of synthetic and chemical biology to engineer the next generation of immune cell therapies for cancer. The lab takes a comprehensive approach to cellular engineering by developing new synthetic receptors, signal transduction cascades, and cellular response programs to enhance the safety and effectiveness of adoptive cell therapies.
Education & Training
- 2013: University of Texas Southwestern Medical Center, PhD, Immunology
- 2005: Austin College, TX, BA Biology